NCT04902092

Brief Summary

Heavy cannabis use is associated with substantive learning and memory impairments and elevated risk of psychopathology. It has been repeatedly demonstrated that the hippocampus, centrally implicated in these processes, is particularly vulnerable to the deleterious effects of prolonged exposure to cannabis. This deterioration of hippocampal structure, function, and biochemistry can be reversed, but this requires two or more years of abstinence from cannabis. However, most heavy cannabis users find it extremely difficult to maintain abstinence over extended periods and current treatments for cannabis use disorders are inadequate. There is a pressing clinical need for an intervention that rapidly accelerates hippocampal recovery, ameliorates the associated cognitive impairments and mental health symptoms, and leads to improved treatment outcomes. One promising candidate is physical exercise. In addition to the well-known physical health benefits, regular exercise also has a potent positive effect on brain health. The current study will investitive the capacity of two different neuroscientifically-informed 12-week exercise programs can restore brain health for heavy long term cannabis users.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
65

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jan 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 23, 2019

Completed
2.3 years until next milestone

First Submitted

Initial submission to the registry

May 13, 2021

Completed
13 days until next milestone

First Posted

Study publicly available on registry

May 26, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 10, 2022

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 21, 2022

Completed
Last Updated

October 23, 2023

Status Verified

October 1, 2023

Enrollment Period

3.4 years

First QC Date

May 13, 2021

Last Update Submit

October 18, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in hippocampal integrity

    Composite score derived from three hippocampal health indices: volume (structural MRI), connectivity (DTI), neuronal health (MRS NAA) calculated as described in Yucel et al (2016), doi:10.1038/tp.2015.201.

    Baseline (0 months), post (3 months)

Secondary Outcomes (14)

  • Change in cannabis use

    Baseline (0 months), post (3 months), follow up (6 months)

  • Change in cannabis dependence

    Baseline (0 months), post (3 months), follow up (6 months)

  • Change in cannabis craving

    Baseline (0 months), post (3 months), follow up (6 months)

  • Change in depression symptoms

    Baseline (0 months), post (3 months), follow up (6 months)

  • Change in anxiety symptoms

    Baseline (0 months), post (3 months), follow up (6 months)

  • +9 more secondary outcomes

Study Arms (2)

High Intensity Physical Training

ACTIVE COMPARATOR

12-week, 36 session, cardiorespiratory-focussed physical exercise program delivered by an accredited exercise physiologist

Behavioral: High Intensity Interval Training

Low Intensity Physical Training

ACTIVE COMPARATOR

12- week, 36 session, strength-focussed physical exercise program delivered by an accredited exercise physiologist

Behavioral: Strength and Resistance Training

Interventions

Exercise sessions will commence with an initial 3-week accustomization period whereby training load will increase incrementally from 2 x 45min sessions with effort peaking at 60% VO2 max (week 1) increasing to 3 x 45minute with effort peaking at 80% VO2max (week 3). Participants will transition to the full HIIT protocol for the remaining weeks. The HIIT component will comprise a work-rest ratio of ≥1:1minutes, with alternating exertion epochs at \>80% VO2max and \<60% VO2max. As VO2max is likely to increase as fitness improves toward the end of the 3-month program, adjustments to HIIT will be made by the exercise physiologist based on real-time heart rate monitoring, ensuring greater accuracy in participants achieving their heart rate targets.

High Intensity Physical Training

Exercise sessions will comprise a combination of strength, coordination and mobility exercises. The strength component will consist of 2-3 sets of resistance exercises at ≤70% of a predicted 1 repetition maximum, targeting all body segments. Heart rate tracking will occur to ensure participants do not exceed 70% v02 (or exceed Lactate Threshold).

Low Intensity Physical Training

Eligibility Criteria

Age20 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Aged 20-55 years
  • Voluntary and able to provide informed consent
  • Fluent in English
  • Current moderate - severe cannabis use disorder
  • Major history of cannabis use (i.e. ≥3 days per week on average for ≥4 of the past 6 years)
  • Capacity to tolerate physical exercise according to 'Fitness to Exercise'

You may not qualify if:

  • Have a history of cardiovascular disease, high blood pressure, musculoskeletal injury or other condition that would preclude safe engagement in VO2 max fitness testing and/or regular physical exercise
  • Severe claustrophobia, non-MR compatible metallic implant, or other contraindication to MRI scanning
  • Lifetime history of significant neurological illness, or moderate - severe brain injury,
  • Current major unstable medical illness or chronic pain condition
  • Lifetime history of schizophrenia, schizoaffective disorder, OCD, PTSD, bipolar disorder
  • Current significant depression or anxiety that precludes ability to reliably engage in the exercise program
  • Current moderate - severe substance use disorder for substances other than cannabis (excluding nicotine)
  • Currently pregnant or lactating
  • Shift work employment schedule within the prior 6-months
  • Have engaged in ≥5 sessions of HITT or resistance training within the past 12-months
  • History of treatment with antipsychotic medications
  • Current participation in psychosocial treatment for substance use disorder
  • Other psychoactive medications or psychosocial treatments will be considered on a case-by-case basis. Where a current psychoactive medication is deemed acceptable, both dose and type must have been stable for a minimum of four weeks prior to baseline assessment, and remain stable throughout the 12-week exercise phase of the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Monash University, BrainPark

Melbourne, Victoria, 3800, Australia

Location

Related Publications (1)

  • Richardson KE, Suo C, Albertella L, Maleki S, Coxon J, Hendrikse J, Hughes S, Pitt J, Kayayan E, Brown C, Nguyen L, Solowij N, Lubman DI, Segrave R, Yucel M. High-Intensity Exercise and Hippocampal Integrity in Adults With Cannabis Use Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2025 Dec 1;82(12):1240-1245. doi: 10.1001/jamapsychiatry.2025.2319.

MeSH Terms

Conditions

Lymphoma, Follicular

Interventions

High-Intensity Interval TrainingResistance Training

Condition Hierarchy (Ancestors)

Lymphoma, Non-HodgkinLymphomaNeoplasms by Histologic TypeNeoplasmsLymphoproliferative DisordersLymphatic DiseasesHemic and Lymphatic DiseasesImmunoproliferative DisordersImmune System Diseases

Intervention Hierarchy (Ancestors)

Physical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaExercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy Modalities

Study Officials

  • Murat Yucel

    Monash University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Research Fellow

Study Record Dates

First Submitted

May 13, 2021

First Posted

May 26, 2021

Study Start

January 23, 2019

Primary Completion

June 10, 2022

Study Completion

November 21, 2022

Last Updated

October 23, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will not share

Locations